Hepatitis B: Screening and treatment;Hépatite B: Dépistage et traitement

Revue Medicale de Bruxelles

Volumn 33, Issue 4, 2012, Pages 215-222

  Mulkay, J P ^a  

^a SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Diagnosis; Hepatitis B; Natural history; Prevention; Treatment

Indexed keywords

ANTIVIRUS AGENT;

DIAGNOSTIC PROCEDURE; HEALTH CARE PERSONNEL; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; PREVALENCE; REVIEW; TREATMENT PLANNING;

DISEASE PROGRESSION; HEPATITIS B; HEPATITIS B, CHRONIC; HUMANS; MASS SCREENING; SEROLOGIC TESTS;

EID: 84867537144     PISSN: 00353639     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Lavanchy D : Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004; 11 : 97-107
2. Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS : A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 2005; 34 : 1329-39 (Pubitemid 41819540)
3. Stevens CE, Beasley RP, Tsui J, Lee WC : Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 1975; 292 : 771-4
4. Doganci T, Uysal G, Kir T, Bakirtas A, Kuyucu N, Doganci L : Horizontal transmission of hepatitis B virus in children with chronic hepatitis B. World J Gastroenterol 2005; 11 : 418-20 (Pubitemid 40125254)
5. Alter MJ, Hadler SC, Margolis HS et al. : The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies. JAMA 1990; 263 : 1218-22 (Pubitemid 20069919)
6. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ : The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 1996; 334 : 1685-90
7. Zhu YY, Mao YZ, Wu WL, Cai QX, Lin XH : Does hepatitis B virus prenatal transmission result in postnatal immunoprophylaxis failure ? Clin Vaccine Immunol 2010; 17 : 1836-41
8. Mast EE, Margolis HS, Fiore AE et al. : A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States : recommendations of the Advisory Committee on Immunization Practices (ACIP). Part 1 : immunization of infants, children, and adolescents. MMWR Recomm Rep 2005; 54 (RR-16) : 1-31
9. Song YM, Sung J, Yang S, Choe YH, Chang YS, Park WS : Factors associated with immunoprophylaxis against vertical transmission of hepatitis B virus. Eur J Pediatr 2007; 166 : 813-8
10. Xu WM, Cui YT, Wang L et al. : Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection : a multicentre, randomized, double-blind, placebo-controlled study. J Viral Hepat 2009; 16 : 94-103
11. Antiretroviral Pregnancy Registry Steering Committee : Antiretroviral Pregnancy Registry International Interim Report for 1 January 1989 through 31 January 2011. Wilmington, NC : Registry Coordinating Center; 2011. Available at : http://www.APRegistry.com (accessed on October 26, 2011)
12. Lok AS, McMahon BJ : Chronic hepatitis B : update 2009. Hepatology 2009; 50 : 661-2
13. Nelson PK, Mathers BM, Cowie B et al. : Global epidemiology of hepatitis B and hepatitis C in people who inject drugs : results of systematic reviews. Lancet 2011; 378 : 571-83
14. Hagan H, McGough JP, Thiede H, Weiss NS, Hopkins S, Alexander ER : Syringe exchange and risk of infection with hepatitis B and C viruses. Am J Epidemiol 1999; 149 : 203-13 (Pubitemid 29053159)
15. Bialek SR, Bower WA, Mottram K et al. : Risk factors for hepatitis B in an outbreak of hepatitis B and D among injection drug users. J Urban Health 2005; 82 : 468-78 (Pubitemid 41191565)
16. Mast EE, Weinbaum CM, Fiore AE et al. : A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States : recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II : immunization of adults. MMWR Recomm Rep 2006 ; 55 (RR-16) : 1-33 ; quiz CE1-4
17. Hyams KC : Risks of chronicity following acute hepatitis B virus infection : a review. Clin Infect Dis 1995; 20 : 992-1000
18. Kao JH : Diagnosis of hepatitis B virus infection through serological and virological markers. Expert Rev Gastroenterol Hepatol 2008; 2 : 553-62
19. McClune AC, Tong MJ : Chronic hepatitis B and hepatocellular carcinoma. Clin Liver Dis 2010; 14 : 461-76
20. Chen CJ, Yang HI, Su J et al. : Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006; 295 : 65-73 (Pubitemid 43042691)
21. Liaw YF, Chu CM, Lin DY, Sheen IS, Yang CY, Huang MJ : Age-specific prevalence and significance of hepatitis B e antigen and antibody in chronic hepatitis B virus infection in Taiwan : a comparison among asymptomatic carriers, chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. J Med Virol 1984; 13 : 385-91
22. Lok AS, Lai CL, Wu PC, Leung EK, Lam TS : Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection. Gastroenterology 1987; 92 : 1839-43 (Pubitemid 17072230)
23. Liaw YF, Sheen IS, Chen TJ, Chu CM, Pao CC : Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection : a prospective study. Hepatology 1991; 13 : 627-31
24. Liu J, Yang HI, Lee MH et al. : Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance : a community-based follow-up study. Gastroenterology 2010; 139 : 474-82
25. Hsu YS, Chien RN, Yeh CT et al. : Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology 2002; 35 : 1522-7
26. Fattovich G : Natural history of hepatitis B. J Hepatol 2003; 39 (Suppl 1) : S50-8
27. Chu CM, Liaw YF : Incidence and risk factors of progression to cirrhosis in inactive carriers of hepatitis B virus. Am J Gastroenterol 2009; 104 : 1693-9
28. Yim HJ, Lok AS : Natural history of chronic hepatitis B virus infection : what we knew in 1981 and what we know in 2005. Hepatology 2006; 43 (2 Suppl 1) : S173-81
29. Lin CL, Liao LY, Wang CS et al. : Basal core-promoter mutant of hepatitis B virus and progression of liver disease in hepatitis B e antigen-negative chronic hepatitis B. Liver Int 2005; 25 : 564-70
30. Liaw YF, Chu CM : Hepatitis B virus infection. Lancet 2009; 373 : 582-92
31. Yu JW, Sun LJ, Zhao YH, Kang P, Li SC : The study of efficacy of lamivudine in patients with severe acute hepatitis B. Dig Dis Sci 2010; 55 : 775-83
32. Iloeje UH, Yang HI, Su J, Jen CL, You SL, Chen CJ : Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology 2006; 130 : 678-86 (Pubitemid 43374518)
33. Chen CJ, Yang HI, Su J et al. : Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006; 295 : 65-73 (Pubitemid 43042691)
34. European Association For The Study Of The Liver : EASL Clinical Practice Guidelines : Management of chronic hepatitis B virus infection. J Hepatol 2012; 57 : 1
35. Janssens HLA, Sonneveld MJ : Management of Hepatitis B infection. Clinical Care Options, 2012